Genetic Testing for Eye Tumor Cuts Surveillance Costs (CME/CE)

(MedPage Today) -- Genetic testing of children with retinoblastoma and their families greatly reduced unnecessary and expensive clinical surveillance among potentially at-risk family members, a study suggested.

Full Story →